FDA Details “Quality Agreements” For Marketers, Contract Manufacturers
This article was originally published in The Tan Sheet
Executive Summary
The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.
You may also be interested in...
Final FDA Quality Agreements Guidance Retains Focus On Commercial Manufacturing
Final US FDA guidance on contract manufacturing quality agreements retains draft version’s focus on commercial activities even though industry asked for it to also cover arrangements between manufacturers and contract partners developing investigational drugs.
People In Brief
Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.
FDA Details “Quality Agreements” For Marketers, Contract Manufacturers
The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.